MA37951B2 - Formulation de comprimé composite bicouche comprenant de l'atorvastatine, de l'irbesartane et du carbonate de magnésium - Google Patents
Formulation de comprimé composite bicouche comprenant de l'atorvastatine, de l'irbesartane et du carbonate de magnésiumInfo
- Publication number
- MA37951B2 MA37951B2 MA37951A MA37951A MA37951B2 MA 37951 B2 MA37951 B2 MA 37951B2 MA 37951 A MA37951 A MA 37951A MA 37951 A MA37951 A MA 37951A MA 37951 B2 MA37951 B2 MA 37951B2
- Authority
- MA
- Morocco
- Prior art keywords
- irbesartane
- atorvastatin
- magnesium carbonate
- tablet formulation
- bilayer tablet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La présente invention concerne une formulation de comprimé composite bicouche comprenant (a) une première couche comportant de l'irbesartane ou son sel pharmaceutiquement acceptable, et (b) une seconde couche comportant de l'atorvastatine ou son sel pharmaceutiquement acceptable et du carbonate de magnésium (m
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120096477A KR20140028971A (ko) | 2012-08-31 | 2012-08-31 | 아토바스타틴, 이르베살탄 및 탄산마그네슘을 포함하는 이층정 복합제제 |
PCT/KR2013/007838 WO2014035188A1 (fr) | 2012-08-31 | 2013-08-30 | Formulation de comprimé composite bicouche comprenant de l'atorvastatine, de l'irbesartane et du carbonate de magnésium |
Publications (2)
Publication Number | Publication Date |
---|---|
MA37951A1 MA37951A1 (fr) | 2018-06-29 |
MA37951B2 true MA37951B2 (fr) | 2019-12-31 |
Family
ID=50183917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA37951A MA37951B2 (fr) | 2012-08-31 | 2013-08-30 | Formulation de comprimé composite bicouche comprenant de l'atorvastatine, de l'irbesartane et du carbonate de magnésium |
Country Status (31)
Country | Link |
---|---|
US (1) | US20150209290A1 (fr) |
EP (1) | EP2890368A4 (fr) |
JP (1) | JP6363079B2 (fr) |
KR (1) | KR20140028971A (fr) |
CN (1) | CN104602677A (fr) |
AR (1) | AR092386A1 (fr) |
AU (1) | AU2013309686B2 (fr) |
BR (1) | BR112015004471A8 (fr) |
CA (1) | CA2882735A1 (fr) |
CL (1) | CL2015000402A1 (fr) |
CR (1) | CR20150115A (fr) |
DO (1) | DOP2015000040A (fr) |
EA (1) | EA030306B1 (fr) |
EC (1) | ECSP15010600A (fr) |
GT (1) | GT201500043A (fr) |
IL (1) | IL237424A0 (fr) |
IN (1) | IN2015DN01463A (fr) |
MA (1) | MA37951B2 (fr) |
MX (1) | MX354800B (fr) |
MY (1) | MY175897A (fr) |
NI (1) | NI201500027A (fr) |
NZ (1) | NZ706472A (fr) |
PE (1) | PE20150935A1 (fr) |
PH (1) | PH12015500394A1 (fr) |
RU (1) | RU2015111546A (fr) |
SG (1) | SG11201500584YA (fr) |
TW (1) | TWI651101B (fr) |
UA (1) | UA115995C2 (fr) |
UY (1) | UY35001A (fr) |
WO (1) | WO2014035188A1 (fr) |
ZA (1) | ZA201502156B (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6981088B2 (ja) * | 2017-01-27 | 2021-12-15 | ニプロ株式会社 | 経口固形製剤 |
CN110913843B (zh) * | 2017-07-17 | 2022-09-13 | 伊莱利利公司 | 药物组合物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5270317A (en) | 1990-03-20 | 1993-12-14 | Elf Sanofi | N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present |
GT199800126A (es) * | 1997-08-29 | 2000-01-29 | Terapia de combinacion. | |
US20030114497A1 (en) | 2001-07-31 | 2003-06-19 | Laman Alani | Pharmaceutical compositions of amlodipine and atorvastatin |
AR060354A1 (es) * | 2006-04-06 | 2008-06-11 | Schering Corp | Terapias de combinacion antagonistas receptor trombina (tra) |
KR20090114322A (ko) * | 2008-04-29 | 2009-11-03 | 한올제약주식회사 | 심혈관계 질환 치료용 약제학적 제제 |
JP5534004B2 (ja) * | 2010-03-29 | 2014-06-25 | アステラス製薬株式会社 | 口腔内崩壊錠 |
KR101248804B1 (ko) * | 2010-05-14 | 2013-03-29 | 한미사이언스 주식회사 | HMG-CoA 환원효소 억제제 및 이베살탄을 포함하는 이층정 약제학적 복합제제 |
-
2012
- 2012-08-31 KR KR1020120096477A patent/KR20140028971A/ko active Search and Examination
-
2013
- 2013-08-29 AR ARP130103083A patent/AR092386A1/es unknown
- 2013-08-30 IN IN1463DEN2015 patent/IN2015DN01463A/en unknown
- 2013-08-30 CN CN201380045377.2A patent/CN104602677A/zh active Pending
- 2013-08-30 MX MX2015002526A patent/MX354800B/es active IP Right Grant
- 2013-08-30 AU AU2013309686A patent/AU2013309686B2/en not_active Ceased
- 2013-08-30 EP EP13833700.1A patent/EP2890368A4/fr not_active Withdrawn
- 2013-08-30 UA UAA201502939A patent/UA115995C2/uk unknown
- 2013-08-30 RU RU2015111546A patent/RU2015111546A/ru unknown
- 2013-08-30 TW TW102131243A patent/TWI651101B/zh not_active IP Right Cessation
- 2013-08-30 US US14/421,467 patent/US20150209290A1/en not_active Abandoned
- 2013-08-30 UY UY0001035001A patent/UY35001A/es not_active Application Discontinuation
- 2013-08-30 JP JP2015529683A patent/JP6363079B2/ja not_active Expired - Fee Related
- 2013-08-30 MA MA37951A patent/MA37951B2/fr unknown
- 2013-08-30 MY MYPI2015700489A patent/MY175897A/en unknown
- 2013-08-30 EA EA201590469A patent/EA030306B1/ru not_active IP Right Cessation
- 2013-08-30 SG SG11201500584YA patent/SG11201500584YA/en unknown
- 2013-08-30 PE PE2015000220A patent/PE20150935A1/es not_active Application Discontinuation
- 2013-08-30 NZ NZ706472A patent/NZ706472A/en not_active IP Right Cessation
- 2013-08-30 CA CA2882735A patent/CA2882735A1/fr not_active Abandoned
- 2013-08-30 WO PCT/KR2013/007838 patent/WO2014035188A1/fr active Application Filing
- 2013-08-30 BR BR112015004471A patent/BR112015004471A8/pt not_active IP Right Cessation
-
2015
- 2015-02-19 CL CL2015000402A patent/CL2015000402A1/es unknown
- 2015-02-24 PH PH12015500394A patent/PH12015500394A1/en unknown
- 2015-02-25 IL IL237424A patent/IL237424A0/en unknown
- 2015-02-26 GT GT201500043A patent/GT201500043A/es unknown
- 2015-02-26 DO DO2015000040A patent/DOP2015000040A/es unknown
- 2015-02-27 NI NI201500027A patent/NI201500027A/es unknown
- 2015-03-05 CR CR20150115A patent/CR20150115A/es unknown
- 2015-03-20 EC ECIEPI201510600A patent/ECSP15010600A/es unknown
- 2015-03-30 ZA ZA2015/02156A patent/ZA201502156B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4249055A3 (fr) | Formes pharmaceutiques orales de tofacitinib à libération prolongée | |
CL2014003171A1 (es) | Composicion liofilizada que comprende al menos una benzodiazepina de formula (i), al menos un excipiente higroscopico seleccionado de disacaridos y dextrano; metodo de preparacion de la composicion farmaceutica. | |
NL1031503A1 (nl) | Stereoscopisch beeldscherm voor omschakelen tussen 2D/3D beelden. | |
IT1404931B1 (it) | Composizioni oftalmiche per la somministrazione di principi attivi liposolubili . | |
EA201690679A1 (ru) | Стабильная фармацевтическая композиция, содержащая амлодипин и валсартан | |
FR3003747B1 (fr) | Systeme pour abouter deux vaisseaux sanguins. | |
UA107967C2 (en) | Pharmaceutical composition in the form of bilayer tablets which contain inhibitor of hmg-coa reductase inhibitor and irbesartan | |
EP3061020A4 (fr) | Système de score de pathogénicité pour génétique clinique humaine | |
EA201390335A1 (ru) | Введение лоркасерина индивидуумам с почечной недостаточностью | |
SG11201510134YA (en) | Real-time multi-functional ecg signal processing system, dspe for the ecg signal processing system, and method thereof | |
EP3008243A4 (fr) | Structures de serviettes feuilletées comportant des macro-algues | |
WO2015073710A3 (fr) | Détection du risque de maladie cardiovasculaire athéroscléreuse et du risque d'infarctus du myocarde | |
JP2011173937A5 (fr) | ||
EA201491517A1 (ru) | N-этил-n-фенил-1,2-дигидро-4,5-дигидрокси-1-метил-2-оксо-3-хинолинкарбоксамид, его получение и применения | |
EP3694522A4 (fr) | Formulation de comprimé pharmaceutique bicouche | |
EP3053893A4 (fr) | Film intercalaire pour verre feuilleté et verre feuilleté | |
GB2504573B (en) | Panel acting as active retarder, method of fabricating the same, and 3-dimensional stereoscopic image displayable system including the panel | |
IT1397313B1 (it) | Unita' di taglio per macchina o pressa di termoforatura e macchina di termoforatura dotata di tale unita' di taglio. | |
MA37951B2 (fr) | Formulation de comprimé composite bicouche comprenant de l'atorvastatine, de l'irbesartane et du carbonate de magnésium | |
WO2011097527A3 (fr) | Immunoprotection de fractions thérapeutiques avec des régions fc améliorées | |
WO2011091410A8 (fr) | Antagonistes de trpv4 | |
EA201190282A1 (ru) | Фармацевтическая композиция, содержащая тамсулозин | |
WO2019059857A3 (fr) | Dispositif pour combiner plusieurs médicaments | |
WO2015044434A3 (fr) | Fluoro-9-méthyl-β-carboline | |
IN2015DN01018A (fr) |